Hansen Medical to Present at the Inaugural BTIG Snowbird Medical Technology and Diagnostics Conference
14 3월 2014 - 10:00PM
Marketwired
Hansen Medical to Present at the Inaugural BTIG Snowbird Medical
Technology and Diagnostics Conference
MOUNTAIN VIEW, CA--(Marketwired - Mar 14, 2014) - Hansen
Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular
robotics, today reported that Peter J. Mariani, Chief Financial
Officer, is scheduled to participate in meetings at the inaugural
BTIG Snowbird Medical Technology and Diagnostics Conference on
Tuesday and Wednesday, March 18 - 19, 2014. The conference is being
held March 18 - 20, 2014 at The Cliff Lodge Hotel in Snowbird,
Utah. The conference will consist of one-on-one meetings and will
not be webcast.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is a
global leader in intravascular robotics, developing products and
technology designed to enable the accurate positioning,
manipulation and control of catheters and catheter-based
technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™
Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related
accessories are intended to facilitate navigation to anatomical
targets in the peripheral vasculature and subsequently provide a
conduit for manual placement of therapeutic devices. The Magellan
9Fr Robotic Catheter has undergone both CE marking and 510(k)
clearance and is commercially available in the European Union, and
the U.S. The Magellan 6Fr Robotic Catheter has undergone 510(k)
clearance in the U.S. and is in limited release for the next
several months in anticipation of more wide-scale commercially
availability later in 2014. In the European Union, the
Company's Sensei® X Robotic Catheter System and Artisan® and
Artisan Extend® Control Catheters are cleared for use during
electrophysiology (EP) procedures, such as guiding catheters in the
treatment of atrial fibrillation (AF), and the Lynx® Robotic
Ablation Catheter is cleared for the treatment of AF. This robotic
catheter system is compatible with fluoroscopy, ultrasound, 3D
surface map and patient electrocardiogram data. In the U.S., the
Company's Sensei X Robotic Catheter System and Artisan and Artisan
Extend Control Catheters are cleared by the U.S. Food and Drug
Administration for manipulation and control of certain mapping
catheters in EP procedures. In the U.S., the Sensei X Robotic
Catheter System is not approved for use in guiding ablation
procedures; this use remains experimental. The U.S. product
labeling therefore provides that the safety and effectiveness of
the Sensei X Robotic Catheter System and Artisan and Artisan Extend
Control Catheter for use with cardiac ablation catheters in the
treatment of cardiac arrhythmias, including AF, have not been
established. Additional information can be found at
www.hansenmedical.com.
"Artisan Extend," "Hansen Medical," "Hansen Medical (with Heart
Design)," "Heart Design (Logo)," "Sensei," "Lynx," "Artisan,"
"Instinctive Motion," "Fine Force Technology," "IntelliSense" are
registered trademarks, and "Magellan" and "Hansen Medical Magellan"
are trademarks of Hansen Medical, Inc. in the U.S. and other
countries.
Investor Contacts: Peter J. Mariani Chief Financial Officer
Hansen Medical, Inc. 650.404.5800 Westwicke Partners, LLC. Mark
Klausner 443.213.0501 Email Contact Mike Piccinino, CFA
443.213.0509 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024